ONEBIO LABS / RESEARCH INFORMATION
PT 141
Research Peptide | Bremelanotide / Melanocortin Receptor Agonist
Technical specifications
| Generic name | Bremelanotide |
|---|---|
| Sequence | Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH (cyclic) |
| Molecular formula | C50H68N14O10 |
| Molecular weight | 1025.2 g/mol |
| CAS | 189691-06-3 |
| PubChem CID | 9941379 |
| Form | Lyophilised peptide |
| Purity / testing | Refer to product-specific batch COA / analytical documentation |
| Intended use | Laboratory and research purposes only |
Bremelanotide is also an approved prescription medicine in some jurisdictions; a research-product page should clearly distinguish the supplied research material from approved medicinal products.
01 / PRODUCT INFORMATION
Product description
PT-141 is the research code historically associated with bremelanotide, a cyclic melanocortin receptor agonist. It is used in receptor-pharmacology and neuroendocrine research involving melanocortin signalling.
02 / RESEARCH CONTEXT
Research overview
Research areas: Melanocortin receptor pharmacology; neuroendocrine signalling; central nervous system receptor research.
03 / PRODUCT INFORMATION
ONE BIOLABS quality
ONE BIOLABS provides research products with product information and available batch documentation where applicable. Batch-specific identity, purity, concentration, salt form, testing and manufacturing claims should be stated only where supported by the applicable Certificate of Analysis or other analytical documentation.
04 / STORAGE
Refrigerate at 2–8°C
Unless the product-specific label or Certificate of Analysis states otherwise, store refrigerated at 2–8°C, protected from direct light, excessive heat and moisture. Keep the container securely closed. Product-specific storage instructions and stability data should take precedence.
Important notice
FOR RESEARCH PURPOSES ONLY. This product information is intended for laboratory and research reference. Products described in this document are not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of disease unless supplied as an appropriately authorised medicinal product through lawful channels. No dosage, administration or therapeutic guidance is provided.
Research findings, especially preclinical findings, should not be interpreted as proof of human safety or efficacy.
Reviews
There are no reviews yet.